AMGEN INC. Archives - Market Exclusive

Home Tags AMGEN INC.

Amgen, Inc. (NASDAQ:AMGN) price target lowered to $212.00 by Morgan Stanley

ME Staff - December 19, 2018

Amgen, Inc. (NASDAQ:AMGN) price target set to $232.00 by Goldman Sachs...

ME Staff - December 10, 2018

Amgen, Inc. (NASDAQ:AMGN) price target set to $220.00 by Jefferies Financial...

ME Staff - December 4, 2018

Amgen, Inc. (NASDAQ:AMGN) price target raised to $204.00 by Citigroup

ME Staff - November 1, 2018

Amgen, Inc. (NASDAQ:AMGN) price target set to $221.00 by Goldman Sachs...

ME Staff - October 31, 2018

Amgen, Inc. (NASDAQ:AMGN) had its Hold rating reiterated by Cantor Fitzgerald...

ME Staff - October 31, 2018

Amgen, Inc. (NASDAQ:AMGN) had its Neutral rating reiterated by JPMorgan Chase...

ME Staff - October 25, 2018

Amgen, Inc. (NASDAQ:AMGN) price target set to $229.00 by Goldman Sachs...

ME Staff - October 12, 2018

Amgen, Inc. (NASDAQ:AMGN) price target set to $192.00 by JPMorgan Chase...

ME Staff - October 9, 2018

Amgen, Inc. (NASDAQ:AMGN) price target set to $223.00 by Cantor Fitzgerald

ME Staff - October 8, 2018

12 3 Page 1 of 3

/* */

EDITOR PICKS

Cannabis Stock News Daily Roundup April 12

April 12, 2019

Market Morning: Alexa Spying, Boeing Sensor History, Macron Spoils Scallop Dinner

April 11, 2019

ICC, AgraFlora to Bring Native Colombian Cannabis Strains to 39K Retail...

April 10, 2019

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.

Tag: AMGEN INC.